(Q45880367)

17 December 2017

title

Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

coagulation factor IX

0 references

myocardial infarction

1 reference

P Mizon

1

1 reference

17 December 2017

J Goudemand

series ordinal

2

1 reference

17 December 2017

B Jude

series ordinal

3

1 reference

17 December 2017

A Marey

series ordinal

4

1 reference

17 December 2017

publication date

1 June 1992

1 reference

17 December 2017

published in

Annals of Hematology

1 reference

17 December 2017

volume

64

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

309-311

1 reference

17 December 2017

Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group

cites work

1 reference

12 December 2020

Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor

1 reference

12 December 2020

Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates

1 reference

12 December 2020

Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate

1 reference

12 December 2020

Vascular lesions in hemophilia B.

1 reference

12 December 2020

Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography

1 reference

12 December 2020

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor

1 reference

12 December 2020

Disseminated intravascular coagulation and infusion of factor-VIII-inhibitor bypassing activity

1 reference

12 December 2020

Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A.

1 reference

12 December 2020

Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid

1 reference

12 December 2020

Principles of in vivo recovery and survival studies of VIII:C.

1 reference

12 December 2020

Acute myocardial infarction, non-bacterial thrombotic endocarditis, and disseminated intravascular coagulation in a severe hemophiliac

1 reference

12 December 2020

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor

1 reference

12 December 2020

Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia

1 reference

12 December 2020

Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A.

1 reference

12 December 2020

Myocardial infarction after factor IX therapy

1 reference

12 December 2020

Fatal myocardial necrosis associated with prothrombin-complex concentrate therapy in hemophilia A.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01695478

1 reference

17 December 2017

1 reference

17 December 2017